These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 17438410

  • 21. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
    Turunen SP, Kummu O, Wang C, Harila K, Mattila R, Sahlman M, Pussinen PJ, Hörkkö S.
    Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
    [Abstract] [Full Text] [Related]

  • 22. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F, Cofan M, Campos B, Guerra R, Campistol JM, Oppenheimer F.
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [Abstract] [Full Text] [Related]

  • 23. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
    Gonçalves I, Gronholdt ML, Söderberg I, Ares MP, Nordestgaard BG, Bentzon JF, Fredrikson GN, Nilsson J.
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1250-5. PubMed ID: 15831809
    [Abstract] [Full Text] [Related]

  • 24. Significant association of lipid peroxidation products with high density lipoproteins.
    Hahn M, Subbiah MT.
    Biochem Mol Biol Int; 1994 Jul; 33(4):699-704. PubMed ID: 7981657
    [Abstract] [Full Text] [Related]

  • 25. Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice.
    Zhou X, Johnston TP, Johansson D, Parini P, Funa K, Svensson J, Hansson GK.
    Atherosclerosis; 2009 Jun; 204(2):381-7. PubMed ID: 19054515
    [Abstract] [Full Text] [Related]

  • 26. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 27. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N, Moh A, Takebayashi S.
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [Abstract] [Full Text] [Related]

  • 28. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [Abstract] [Full Text] [Related]

  • 29. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M, Kiechl S, Tsimikas S, Miller E, Sheldon J, Willeit J, Witztum JL, Xu Q.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2436-43. PubMed ID: 16781371
    [Abstract] [Full Text] [Related]

  • 30. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J, Manzanares JM, Marimón F, Cabré A, Heras M, Guardiola M, Ribalta J, Masana L.
    Nutr Metab Cardiovasc Dis; 2008 Jun 20; 18(5):380-7. PubMed ID: 17904830
    [Abstract] [Full Text] [Related]

  • 31. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
    Schiopu A, Bengtsson J, Söderberg I, Janciauskiene S, Lindgren S, Ares MP, Shah PK, Carlsson R, Nilsson J, Fredrikson GN.
    Circulation; 2004 Oct 05; 110(14):2047-52. PubMed ID: 15451805
    [Abstract] [Full Text] [Related]

  • 32. The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies.
    van Leeuwen M, Damoiseaux J, Duijvestijn A, Heeringa P, Gijbels M, de Winther M, Tervaert JW.
    Ann N Y Acad Sci; 2009 Sep 05; 1173():274-9. PubMed ID: 19758162
    [Abstract] [Full Text] [Related]

  • 33. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C, Di Giacomo S, Vivenzio A, Isacchi GC, Masella R, Caprari P, Varì R, Tarzia A, Mosiello A, Cantafora A.
    Clin Sci (Lond); 2001 Feb 05; 100(2):191-8. PubMed ID: 11171288
    [Abstract] [Full Text] [Related]

  • 34. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Hörkkö S, Witztum JL.
    Arthritis Rheum; 2005 Jan 05; 52(1):192-200. PubMed ID: 15641060
    [Abstract] [Full Text] [Related]

  • 35. Decomposition of lipid hydroperoxides enhances the uptake of low density lipoprotein by macrophages.
    Babiy AV, Gebicki JM.
    Acta Biochim Pol; 1999 Jan 05; 46(1):31-42. PubMed ID: 10453979
    [Abstract] [Full Text] [Related]

  • 36. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
    Habets KL, van Puijvelde GH, van Duivenvoorde LM, van Wanrooij EJ, de Vos P, Tervaert JW, van Berkel TJ, Toes RE, Kuiper J.
    Cardiovasc Res; 2010 Feb 01; 85(3):622-30. PubMed ID: 19819882
    [Abstract] [Full Text] [Related]

  • 37. Increase in plasma malondialdehyde-modified low-density lipoprotein in patients with atherothrombotic cerebral infarction.
    Kametsu Y, Kitagawa Y, Sekiyama S, Takagi S.
    Tokai J Exp Clin Med; 2005 Sep 01; 30(3):171-6. PubMed ID: 16285608
    [Abstract] [Full Text] [Related]

  • 38. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z, Mrzljak V, Turk N, Metelko Z.
    Diabetes Nutr Metab; 1999 Dec 01; 12(6):413-7. PubMed ID: 10782563
    [Abstract] [Full Text] [Related]

  • 39. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A, Hennuyer N, Tailleux A, Furman C, Duverger N, Caillaud JM, Castro G, Fievet C, Fruchart JC, Duriez P.
    Clin Sci (Lond); 2001 Mar 01; 100(3):343-55. PubMed ID: 11222122
    [Abstract] [Full Text] [Related]

  • 40. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J, Jeyasekharan AD, Theunissen R, Tervaert JW.
    Ann N Y Acad Sci; 2005 Jun 01; 1050():163-9. PubMed ID: 16014530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.